Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis

Digestive and Liver Disease

Volumn 48, Issue 3, 2016, Pages 283-290

  Calzadilla Bertot, Luis ^a   Vilar Gomez, Eduardo ^a,d   Torres Gonzalez, Ana ^a   Socias Lopez, Maray ^a   Diago, Moises ^b   Adams, Leon A ^c   Romero Gomez, Manuel ^d  

^a INSTITUTO DE GASTROENTEROLOGÍA   (Cuba)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

2 h plasma glucose; Hepatic decompensation; Insulin resistance; Overall survival; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ADVERSE OUTCOME; ARTICLE; ASCITES; BLEEDING; BRAIN DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIABETIC PATIENT; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEPATITIS C VIRUS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE COUNT; AGED; CHRONIC HEPATITIS C; COMPLICATION; GLUCOSE TOLERANCE TEST; LIVER FAILURE; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84961052744     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.12.002     Document Type: Article

References (42)

1. White D.L., Ratziu V., El-Serag H.B. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. Journal of Hepatology 2008, 49:831-844.
2. Veldt B.J., Chen W., Heathcote E.J., et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008, 47:1856-1862.
3. Garcia-Compean D., Jaquez-Quintana J.O., Gonzalez-Gonzalez J.A., et al. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World Journal of Gastroenterology: WJG 2009, 15:280-288.
4. Harrison S.A. Liver disease in patients with diabetes mellitus. Journal of Clinical Gastroenterology 2006, 40:68-76.
5. Garcia-Compean D., Jaquez-Quintana J.O., Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Annals of Hepatology 2009, 8:13-20.
6. Hajarizadeh B., Grebely J., Dore G.J. Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology & Hepatology 2013, 10:553-562.
7. Naing C., Mak J.W., Ahmed S.I., et al. Relationship between hepatitis C virus infection type 2 diabetes mellitus: meta-analysis. World Journal of Gastroenterology: WJG 2012, 18:1642.
8. Huang J.F., Yu M.L., Dai C.Y., et al. Glucose abnormalities in hepatitis C virus infection. The Kaohsiung Journal of Medical Sciences 2013, 29:61-68.
9. Zein N.N., Abdulkarim A.S., Wiesner R.H., et al. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. Journal of Hepatology 2000, 32:209-217.
10. Henry L., Younossi Z. Hepatitis. Chronic HCV infection, diabetes and liver-related outcomes. Nature Reviews Gastroenterology & Hepatology 2014, 11:520-521.
11. Kaddai V., Negro F. Current understanding of insulin resistance in hepatitis C. Expert Review of Gastroenterology & Hepatology 2011, 5:503-516.
12. Huang Y.W., Yang S.S., Fu S.C., et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study. Hepatology 2014, 60:807-814.
13. Eslam M., Ampuero J., Jover M., et al. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables. Annals of Hepatology 2013, 12:588-598.
14. Berzigotti A., Abraldes J.G. Impact of obesity and insulin-resistance on cirrhosis and portal hypertension. Gastroenterologia y hepatologia 2013, 36:527-533.
15. Camma C., Petta S., Di Marco V., et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology 2009, 49:195-203.
16. Lecube A., Hernandez C., Genesca J., et al. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care 2006, 29:1140-1149.
17. van der Meer A.J., Veldt B.J., Feld J.J., et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012, 308:2584-2593.
18. Gomez E.V., Rodriguez Y.S., Bertot L.C., et al. The natural history of compensated HCV-related cirrhosis: a prospective long-term study. Journal of Hepatology 2013, 58:434-444.
19. van Walraven C., Davis D., Forster A.J., et al. Time-dependent bias was common in survival analyses published in leading clinical journals. Journal of Clinical Epidemiology 2004, 57:672-682.
20. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(Suppl 1):S5-S10.
21. Putter H., Fiocco M., Geskus R.B. Tutorial in biostatistics: competing risks and multi-state models. Statistics in Medicine 2007, 26:2389-2430.
22. Wolbers M., Koller M.T., Witteman J.C., et al. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 2009, 20:555-561.
23. Vittinghoff E., McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology 2007, 165:710-718.
24. Bianchi G., Marchesini G., Zoli M., et al. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994, 20:119-125.
25. Sangiovanni A., Prati G.M., Fasani P., et al. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 2006, 43:1303-1310.
26. Elkrief L., Chouinard P., Bendersky N., et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 2014, 60:823-831.
27. Quintana J., García-Compean D., González J., et al. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis - a prospective study. Annals of Hepatology 2011, 10:56-62.
28. Ratziu V., Munteanu M., Charlotte F., et al. Fibrogenic impact of high serum glucose in chronic hepatitis C. Journal of Hepatology 2003, 39:1049-1055.
29. D'Souza R., Sabin C.A., Foster G.R. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. American Journal of Gastroenterology 2005, 100:1509-1515.
30. Fartoux L., Poujol-Robert A., Guechot J., et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005, 54:1003-1008.
31. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003, 125:1695-1704.
32. El-Serag H.B., Tran T., Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004, 126:460-468.
33. Erice E., Llop E., Berzigotti A., et al. Insulin resistance in patients with cirrhosis and portal hypertension. American Journal of Physiology - Gastrointestinal and Liver Physiology 2012, 302:G1458-G1465.
34. García-Pagán J.-C., Gracia-Sancho J., Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. Journal of Hepatology 2012, 57:458-461.
35. Nkontchou G., Bastard J.-P., Ziol M., et al. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. Journal of Hepatology 2010, 53:827-833.
36. Nishida T., Tsuji S., Tsujii M., et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. American Journal of Gastroenterology 2006, 101:70-75.
37. Jeon H.K., Kim M.Y., Baik S.K., et al. Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Digestive Diseases and Sciences 2013, 58:3335-3341.
38. Grancini V., Trombetta M., Lunati M.E., et al. Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease. Journal of Hepatology 2015, 63:1484-1490.
39. Tolman K.G., Fonseca V., Dalpiaz A., et al. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007, 30:734-743.
40. Picardi A., D'Avola D., Gentilucci U.V., et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes/Metabolism Research and Reviews 2006, 22:274-283.
41. Ishikawa T., Shiratsuki S., Matsuda T., et al. Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. Journal of Gastroenterology 2014, 49:1333-1341.
42. Petrides A.S., DeFronzo R.A. Glucose and insulin metabolism in cirrhosis. Journal of Hepatology 1989, 8:107-114.